Antifungal properties of Chenopodium ambrosioides essential oil against candida species

Pharmaceuticals

Volumn 3, Issue 9, 2010, Pages 2900-2909

  Chekem, Marie Stéphanie Goka ^a   Lunga, Paul Keilah ^a   Tamokou, Jean de Dieu ^a   Kuiate, Jules Roger ^a   Tane, Pierre ^a   Vilarem, Gerard ^b   Cerny, Muriel ^b  

^a UNIVERSITY OF DSCHANG   (Cameroon)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Antifungal; Chenopodium ambrosioides; Essential oil; Fatty acids profie; Yeasts

Indexed keywords

ESSENTIAL OIL; FATTY ACID; NYSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA; CHENOPODIUM AMBROSIOIDES; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG SCREENING; FATTY ACID ANALYSIS; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LIPOGENESIS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; RAT; VAGINA CANDIDIASIS; YEAST;

EID: 77957276685     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph3092900     Document Type: Article

References (29)

1. Klepser, M.E. Antifungal resistance among Candida species. Pharmacotherapy 2001, 21, 124s-132s.
2. Mohammad, A.H.; Shigefumi, M.; Kotaro, M.; Hiroshi, K.; Eisuke, S.; Kazunori, T.; Takayoshi, T.; Shigera, K. In vitro and in vivo activities of SCH56592 against Cryptococcus neoformans. J. Antimicrob. Chemother. 1999, 44, 827-829.
3. Sean, O.H.; Renee, N.M. Candidiasis. Emerg. Med. 2006, 19, 1-11.
4. Fidel, P.; Lynch, M.E.; Sobel, J.D. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis. Infect. Immunol. 1993, 61, 4201-4207.
5. Goff, D.A.; Koletar, S.L.; Buesching, W.J.; Banishan, J.; Fass, R.J. Isolation of fluconazoleresitant Candida albicans from human immunodeficiency virus negative patients never treated with azole. Clin. Infect. Dis. 1995, 20, 77-83.
6. Dupont, B.F.; Dromer, F.; Improvisi, L. The problem of resistance to azoles in Candida. J. Med. Mycol. 1996, 6, 12-19.
7. Heeres, J.; Meerpoel, L.; Lewi, P. Conazoles. Molecules 2010, 15, 4129-4188.
8. Ellepolla, A.N.B.; Samaranayake, L.P. Oral candidal infections and antimycotics. Rev. Oral Biol. Med. 2000, 11, 172-198.
9. Georgopadakou, N.A.; Dix, B.A.; Smith, S.A.; Freudenberger, J. Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans. Antimicrob. Agents Chemother. 1987, 31, 46-51.
10. Kauffman, C.A.; Carver, P.L. Antifungal agents in the 1990s. Current status and future developments. Drugs. 1997, 53, 539-549.
11. Mondello, F.; De Bernardis, F.; Girolamo, A.; Cassone, A.; Salvatore, G. In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and resistant human pathogenic Candida species. BMC Infect Dis. 2006, 6, 1-8.
12. Kishore, N.; Chansouria, J.P.N.; Dubey, N.K. Antidermatophytic action of the essential oil of Chenopodium ambrosioides and an ointment prepared from it. India Phytother. Res. 1999, 10, 453-455.
13. Jardim, C.M.; Jham, G.N.; Dhingra, O.D.; Freire, M.M. Composition and antifungal activity of the essential oil of the Brazilian Chenopodium ambrosioides L. J. Chem. Ecol. 2008, 34, 1213-1218.
14. Kumar, R.; Kumar, M.A.; Dubey, N.K.; Tripathi, Y.B. Evaluation of Chenopodium ambroisioides oil as a potential source of antifungal, antiaflatoxigenic and antioxidant activity. Int. J. Food Microbiol. 2007, 115, 159-164.
15. Potawale, S.E.; Luniya, K.P.; Mantri, R.A.; Mehta, U.K.; Waseem M.D.; Sadiq M.D.; Vetal, Y.D.; Deshmukh, R.S. Chenopodium ambrosioides: An ethnopharmacological review. Pharmacologyonline 2008, 2, 272-286.
16. Tapondjou, A.L.; Adler, C.; Bouda, H.; Fontem, A.D. Bioefficacy of powders and essential oil from leaves of C. ambrosoides and E. saligna to the cowpea bruchid Collosobruchus maculates Fab. (coleoptera. Bruchidae). Cahiers d'études et de Recherches Francophones/Agricultures 2003, 12, 401-408.
17. Figueiredo, A.C.; Barroso, J.G.; Pedro, L.G.; Scheffer J.J.C. Factors affecting secondary metabolite production in plants: volatile components and essential oils. Flavor Frag. J. 2008, 23, 213-226.
18. Onocha, P.A.; Ekundayo, O.; Eramo, T.; Laakso, I. Essential oil constituents of Chenopodium ambrosioides L. leaves from Nigeria. J. Essent. Oil Res. 1999, 11, 220-222.
19. Gupta, D.; Charles, R.; Mehta, V.K.; Garg, S.N.; Kumar, S. Chemical examination of the essential oil of Chenopodium ambrosioides L. from the southern hills of India. J. Essent. Oil Res. 2002, 14, 93-94.
20. Koba, K.; Catherine, G.; Raynaud, C.; Chaumont J.P.; Sanda, K.; Laurence, N. Chemical composition and cytotoxic activity of Chenopodium ambrosioides L. essential oil from Togo. Bangladesh J. Sci. Ind. Res. 2009, 44, 435-440.
21. Cavalli, J.F.; Tomi, F.; Bermadini, A.F.; Casanova, J. Combined Analysis of the Essential oil of Chenopodium ambrosioides by GC, GC-MS and 13C NMR Spectroscopy: Quantitative Determination of Ascaridole, a Heat Sensitive Compound. Phytochem. Anal. 2004, 15, 275-279.
22. Mondello, F.; De Bernardis, F.; Girolamo, A.; Salvatore, G.; Cassone, A. In vitro and in vivo activity of tea tree oil against azole-susceptible and resistant human pathogenic yeasts. J. Antimicrob. Chemother. 2003, 51, 1223-1229.
23. Giorgione, J.; Epand, R.M.; Buda, C.; Farkas, T. Role of phospholipids containing docohexaenoyl chains in modulating the activity of protein kinase C. Proc. Natl. Acad. Sci. USA 1995, 92, 9767-9770.
24. Ntambi, J.M.; Bene, H. Polyunsaturated fatty acid regulation of gene expression. J. Mol. Neurosci. 2001, 16, 273-278.
25. Ells, R.; Kock, J.L.F.; Van Wyk, P.W.J.; Botes, P.J.; Pohl, C.H. Arachidonic acid increases antifungal susceptibility of Candida albicans and Candida dubliniensis. J. Antimicrob. Chemother. 2009, 63, 124-128.
26. Shigeharu, I.; Miki, T.; Shigeru, A. Inhibitory activity of hydrosols, herbal teas and related essential oils against filament formation and growth of Candida albicans. Jpn. J. Med. Mycol. 2009, 50, 243-251.
27. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard M27-A2. National Committee for Clinical Laboratory Standards: Wayne, PA, USA, 2002.
28. Tamokou, J.D.; Tala, F.M.; Wabo, H.K.; Kuiate, J.R.; Tane, P. Antimicrobial activities of methanol extract and compounds from stem bark of Vismia rubescens. J. Ethnopharmacol. 2009, 124, 571-575.
29. Da Silva, M.; Manfio, G.P.; Canhos, V.P. Characterization of selected strain of Mucorales using fatty acid profiles. Rev. Microbiol. 1998, 29, 1-8.